Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Diagnosis of Schizophrenia and OCD for at least 6 months
Minimum score of 14 on YBOCS
Minimum score of 60 on PANSS
Diagnosis of Schizophrenia without OC symptoms
Patients who are already being treated with ziprasidone
Diagnosis of schizophreniform disorder
Organic brain syndrome, mental retardation and pervasive developmental disorder
Patients having any significantly cardiovascular illness or electrolyte imbalance